A Closer Look at Nonalcoholic Fatty Liver Disease (NAFLD)
- Share via
Key Facts
- NAFLD is a chronic liver disease caused by fat buildup in the liver, even with little to no alcohol use.
- Risk factors for NAFLD include being overweight or obese, having type 2 diabetes, high cholesterol, high blood pressure, or other signs of metabolic syndrome.
- Many people with NAFLD do not notice clear symptoms in early stages, but some may experience fatigue or mild abdominal pain.
- NAFLD can be managed through lifestyle changes such as weight loss, a healthy diet, and regular exercise.
- If ignored, NAFLD can progress to more serious conditions like NASH, cirrhosis, and potentially liver cancer.
Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease that appears when too much fat accumulates in the liver despite limited or zero alcohol use. It is strongly linked to having extra weight, diabetes, and issues with metabolism. In many places, NAFLD has become a major health concern that affects different age groups and backgrounds, with its impact growing as lifestyle habits change across the globe [1].
Table of Contents
- What is NAFLD?
- How Does NAFLD Develop?
- Who is at Risk for NAFLD?
- What Are the Symptoms?
- How is NAFLD Diagnosed?
- How Can NAFLD Be Managed?
- Are There Medications for NAFLD?
- Long-Term Outlook and Prevention
- Closing Thoughts
- References
What is NAFLD?
NAFLD happens when fat builds up in liver cells, causing strain on the liver over time. Unlike alcoholic fatty liver disease, which is caused by heavy alcohol consumption, NAFLD occurs in individuals who drink little to no alcohol. Although some people may assume that only heavy drinkers develop liver problems, NAFLD shows it can also affect individuals who drink little to no alcohol at all. When identified early, it can be managed through everyday choices that support overall well-being. This is one of many diseases specific to the liver such as Bile Ducts inflammation and Hepatitis B, Hepatitis C, Hepatitis D, and Hepatitis E.
How Does NAFLD Develop?
This condition usually develops when certain factors work together in the body:
- Excess Fat Accumulation: Eating too many calories, along with sugary and fatty foods, can lead to extra fat being stored in the liver.
- Adipose Tissue Dysfunction: Having a lot of belly fat means the body might release more inflammatory substances called adipokines, which contribute to low-level inflammation that can slowly damage the liver [1]. This low-level inflammation can slowly lead to liver damage over time.
- Insulin Resistance: When cells do not respond well to insulin, the body struggles to process sugar and fat normally, causing more fat to be stored in liver cells [2].
- Metabolic Syndrome Connection: NAFLD often goes hand in hand with metabolic syndrome. This syndrome includes large waist circumference, unusual cholesterol levels, high blood sugar, and raised blood pressure [3].
Who is at Risk for NAFLD?
Certain groups of people are more likely to develop NAFLD due to lifestyle and health factors. Individuals who are overweight or obese, especially those with belly fat, have a higher chance of getting NAFLD. People with type 2 diabetes, high cholesterol, high blood pressure, or other signs of metabolic syndrome also face an increased risk [1, 3]. Keeping an eye on these issues can help someone spot warning signs and work on early prevention. Monitoring these risk factors can help in early detection and prevention of NAFLD and other liver diseases.
What Are the Symptoms?
Many people with NAFLD do not notice clear symptoms in early stages. The liver may quietly suffer until more damage is done. A few might feel extra tired or notice a slight pain on the right side of their upper abdomen. Others learn about possible liver trouble through a blood test that shows raised liver enzymes, such as ALT and AST.
How is NAFLD Diagnosed?
Doctors use several methods to figure out if someone has NAFLD:
- Imaging Tests: Ultrasounds, CT scans, or MRIs can show if there is too much fat in the liver.
- Blood Tests: Measuring the levels of liver enzymes (ALT, AST) can reveal if liver cells are irritated. [4]
- Liver Biopsy: In some cases, a tiny piece of liver tissue might be taken and studied under a microscope to confirm how advanced the condition is. This approach is viewed as the “gold standard” for diagnosing NASH, which is the more serious form of NAFLD [1]. A liver biopsy can also help determine the extent of liver damage and guide treatment options.
How Can NAFLD Be Managed?
The good news is that many steps can help manage NAFLD:
- Lifestyle Changes: Losing weight through a balanced approach can ease stress on the liver. In fact, a reduction of even 5-10% of total body weight might lower the amount of fat and inflammation in this organ.
- Healthy Diet: Eating foods like vegetables, fruits, whole grains, fish, and olive oil (as part of a Mediterranean-style plan) helps supply the body with key nutrients and reduces junk food intake. These dietary changes can significantly improve liver health and reduce the risk of further complications.
- Regular Exercise: Experts advise around 150 minutes of activity per week. Something as simple as daily walks can make a noticeable difference in a person’s health.
Are There Medications for NAFLD?
Currently, there are no specific, FDA-approved drugs just for NAFLD. However, some doctors may consider certain supplements like Vitamin E for those without diabetes but who have a confirmed advanced form called NASH [2]. Meanwhile, fresh treatments that target inflammation and scarring in the liver are being examined in clinical trials, holding promise for the future. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is actively supporting research on NAFLD and related conditions, including digestive and kidney diseases.
Long-Term Outlook and Prevention
Many people with NAFLD remain stable if they adopt a healthier lifestyle. But if ignored, NAFLD may progress to nonalcoholic steatohepatitis (NASH), where inflammation and severe damage to liver cells occur. In the worst cases, that can eventually lead to cirrhosis (heavy scarring) and increase the risk of liver cancer, sometimes referred to as hepatocellular carcinoma (HCC). This risk goes up if someone already has metabolic syndrome [3]. In severe cases, cirrhosis can lead to liver failure, necessitating a liver transplant.
When it comes to stopping this disease before it develops, the best actions often include maintaining a balanced weight, cutting back on sugary drinks and refined foods, and staying active every week. Managing diabetes, blood pressure, and cholesterol can also help keep the liver healthy [2].
Closing Thoughts
NAFLD is a widely recognized health issue that is closely tied to being overweight, having metabolic syndrome, and dealing with insulin resistance. Although it can be silent at first, paying attention to risk factors and making healthy lifestyle decisions can stop or even reverse serious outcomes. Researchers continue to search for effective drug therapies, but the foundation of prevention and care remains a balanced diet, regular exercise, and weight management. It is important to differentiate NAFLD from alcohol related liver disease, which has different causes and treatment approaches.
References
[1] Jung, U. J., & Choi, M. S. (2014). Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. International journal of molecular sciences, 15(4), 6184–6223. https://doi.org/10.3390/ijms15046184
[2] Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014). Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes research and clinical practice, 105(2), 141–150. https://doi.org/10.1016/j.diabres.2014.04.006
[3] Engin A. (2017). The Definition and Prevalence of Obesity and Metabolic Syndrome. Advances in experimental medicine and biology, 960, 1–17. https://doi.org/10.1007/978-3-319-48382-5_1
[4] Varra, F. N., Varras, M., Varra, V. K., & Theodosis-Nobelos, P. (2024). Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review). Molecular medicine reports, 29(6), 95. https://doi.org/10.3892/mmr.2024.13219
